Earlier this year, the National Comprehensive Cancer Network® released its 2014 Clinical Practice Guidelines in Oncology® which now includes stereotactic body radiation therapy as a treatment option for prostate cancer. Developed and updated annually by nearly 950 clinical professionals, the guidelines help individuals involved in cancer care, including physicians, nurses, patients and their families, with the process of making informed, evidence-based treatment decisions.
Additionally, the American College of Radiology recently updated its Appropriateness Criteria for early stage prostate cancer indicating that SBRT may help patients diagnosed with the disease. The organization is made up of 36,000 health care professionals, including radiologists, radiation oncologists, medical physicists and other allied health professionals.
Reno CyberKnife treats prostate cancer using CyberKnife® technology. If you or a loved one has been diagnosed with prostate cancer, contact our center to learn if you are a candidate for CyberKnife treatment.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.